| Popis: |
The purpose of this chapter is to review the adverse effects associated with neuromuscular blocking agents and skeletal muscle relaxants. A literature search using PubMed, Medline, and Cochrane (January 2020–December 2020) was performed utilizing keywords: succinylcholine, suxamethonium, atracurium, cisatracurium, mivacurium, pancuronium, rocuronium, vecuronium, gantacurium, CW002, CW011, adamgammadex, sugammadex, neostigmine, calabadion, L-cysteine, baclofen, carisoprodol, chlorzoxazone, cyclobenzaprine, dantrolene, metaxalone, methocarbamol, orphenadrine, tizanidine, neuromuscular blocking agents, skeletal muscle relaxants, adverse effects, and side effects. All English-language reports during the specified year were included for this review. Adverse effects were reported for the following medications between January 2020 and December 2020: succinylcholine (suxamethonium), cisatracurium, rocuronium, neostigmine, adamgammadex, sugammadex, baclofen, metaxalone, and tolperisone. This chapter outlines the findings from the identified articles including adverse effects, suspected mechanisms underlying these effects, and implications to clinical practice and patient care. |
